Michael Braun
Universität Ulm(DE)German Red Cross(DE)Krankenhaus vom Roten Kreuz(DE)Virenze(NL)Breast Center(CH)Universitätsklinikum Würzburg(DE)The Christie NHS Foundation Trust(GB)Rotkreuzklinikum München(DE)University Hospital Ulm(DE)Leipzig University(DE)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Colorectal Cancer Treatments and Studies, Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer(2019)1,423 cited
- → Predictive Biomarkers of Chemotherapy Efficacy in Colorectal Cancer: Results From the UK MRC FOCUS Trial(2008)275 cited
- → Genetic Markers of Toxicity From Capecitabine and Other Fluorouracil-Based Regimens: Investigation in the QUASAR2 Study, Systematic Review, and Meta-Analysis(2014)256 cited
- → Functional Outcome Following Stroke Thrombectomy in Clinical Practice(2019)250 cited
- → Prevalence of BRCA1/2 germline mutations in 21 401 families with breast and ovarian cancer(2016)222 cited
- → Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response(2022)218 cited